The Department of Health and Social Care (DHSC) has proposed to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% in the second half of 2025.
NHS England will be brought into the Department of Health and Social Care (DHSC) entirely over the next two years, health secretary Wes Streeting told the House of Commons.